We are live on ! Find out more
SIS

Sound Income Strategies Portfolio holdings

AUM $2.23B
1-Year Est. Return 11.22%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+11.22%
3 Year Est. Return
+31.18%
5 Year Est. Return
+22.88%
10 Year Est. Return
AUM
$2.11B
AUM Growth
+$284M
Cap. Flow
+$187M
Cap. Flow %
8.86%
Top 10 Hldgs %
22.37%
Holding
2,583
New
899
Increased
864
Reduced
240
Closed
69

Sector Composition

Rank Sector Weight
1 Financials 28.47%
2 Real Estate 10.15%
3 Technology 5.79%
4 Consumer Discretionary 5.5%
5 Healthcare 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRPM icon
1326
Invesco S&P MidCap 400 GARP ETF
GRPM
$509M
$13K ﹤0.01%
+106
New +$12.6K
MAA icon
1327
Mid-America Apartment Communities
MAA
$15.6B
$13K ﹤0.01%
95
+73
+332% +$9.73K
UIS icon
1328
Unisys
UIS
$208M
$13K ﹤0.01%
+4,059
New +$12.7K
FNDA icon
1329
Schwab Fundamental US Small Company Index ETF
FNDA
$9.45B
$13K ﹤0.01%
384
TEM
1330
Tempus AI
TEM
$9.49B
$12.9K ﹤0.01%
184
NMIH icon
1331
NMI Holdings
NMIH
$3.43B
$12.9K ﹤0.01%
340
+334
+5,567% +$12.6K
EMBC icon
1332
Embecta
EMBC
$293M
$12.9K ﹤0.01%
1,042
+1,021
+4,862% +$13.5K
FID icon
1333
First Trust Exchange-Traded Fund VI First Trust S&P International Dividend Aristocrats ETF
FID
$173M
$12.9K ﹤0.01%
+616
New +$12.4K
AVSU icon
1334
Avantis Responsible US Equity ETF
AVSU
$491M
$12.9K ﹤0.01%
164
AZZ icon
1335
AZZ Inc
AZZ
$4.51B
$12.9K ﹤0.01%
+104
New +$10.8K
BEAM icon
1336
Beam Therapeutics
BEAM
$2.72B
$12.8K ﹤0.01%
+409
New +$10.4K
IFV icon
1337
First Trust Dorsey Wright International Focus 5 ETF
IFV
$238M
$12.8K ﹤0.01%
+494
New +$12K
PDT
1338
John Hancock Premium Dividend Fund
PDT
$627M
$12.8K ﹤0.01%
996
-1,608
-62% -$20.8K
GAEM
1339
Simplify Gamma Emerging Market Bond ETF
GAEM
$41M
$12.7K ﹤0.01%
474
+370
+356% +$9.83K
AUPH icon
1340
Aurinia Pharmaceuticals
AUPH
$2.04B
$12.6K ﹤0.01%
+851
New +$12.1K
TTD icon
1341
Trade Desk
TTD
$6.64B
$12.6K ﹤0.01%
355
EMBJ
1342
Embraer S.A. ADS
EMBJ
$13.4B
$12.6K ﹤0.01%
171
MDGL icon
1343
Madrigal Pharmaceuticals
MDGL
$11.8B
$12.5K ﹤0.01%
+25
New +$12.8K
MNRO icon
1344
Monro
MNRO
$355M
$12.5K ﹤0.01%
591
+110
+23% +$2.02K
MGNX icon
1345
MacroGenics
MGNX
$249M
$12.5K ﹤0.01%
7,262
FNDB icon
1346
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.48B
$12.5K ﹤0.01%
453
ECL icon
1347
Ecolab
ECL
$77.3B
$12.5K ﹤0.01%
45
+23
+105% +$6.13K
ATO icon
1348
Atmos Energy
ATO
$28.7B
$12.5K ﹤0.01%
73
+18
+33% +$3.11K
STIP icon
1349
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$12.4K ﹤0.01%
122
-394
-76% -$40.6K
TRFK icon
1350
Pacer Data and Digital Revolution ETF
TRFK
$1.06B
$12.4K ﹤0.01%
+190
New +$12.9K

Similar funds

Sound Income Strategies's Q4 2025 Portfolio in Review

As of Q4 2025, Sound Income Strategies held 2,583 positions worth $2.11B, up 16% from $1.83B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sound Income Strategies deployed $187M of net new capital in Q4 2025, opening 899 new positions and adding to 864 existing holdings. Its largest new stake was T. Rowe Price Blue Chip Growth ETF: 186,568 shares worth $9.22M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 28% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was LyondellBasell Industries, an estimated $14.4M trimmed.

  • Sound Income Strategies's largest Q4 2025 buy was T. Rowe Price Blue Chip Growth ETF: 186,568 shares worth $9.22M.
  • Sound Income Strategies added most to Trinity Capital Inc. in Q4 2025, an estimated $14.1M increase.
  • Sound Income Strategies's biggest Q4 2025 reduction was LyondellBasell Industries, cutting an estimated $14.4M.
  • Sound Income Strategies fully exited Amcor in Q4 2025, selling an estimated $14.3M.
  • Sound Income Strategies's ten largest holdings make up 22% of its $2.11B portfolio in Q4 2025.
  • Sound Income Strategies opened 899 new positions and closed 69 in Q4 2025.
  • Sound Income Strategies's portfolio value rose 16% quarter-over-quarter to $2.11B.

Based on Sound Income Strategies's 13F filing for Q4 2025, filed 21 Jan 2026.